Small-Molecule Parkinson's Disease Kinase Inhibitor LRRK2-in-1 Demonstrates Potent Anti-Cancer Activity Through Inhibition of DCLK1

被引：0
|
作者：
Weygant, Nathaniel
Qu, Dongfeng
Berry, William L.
May, Randal
Chandrakesan, Parthasarathy
Owen, Daniel
Ali, Naushad
Janknecht, Ralf
Sureban, Sripathi M.
Houchen, Courtney W.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1929
引用
收藏
页码：S694 / S694
页数：1
相关论文
共 46 条
  • [1] Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
    Weygant, Nathaniel
    Qu, Dongfeng
    Berry, William L.
    May, Randal
    Chandrakesan, Parthasarathy
    Owen, Daniel B.
    Sureban, Sripathi M.
    Ali, Naushad
    Janknecht, Ralf
    Houchen, Courtney W.
    MOLECULAR CANCER, 2014, 13
  • [2] Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
    Nathaniel Weygant
    Dongfeng Qu
    William L Berry
    Randal May
    Parthasarathy Chandrakesan
    Daniel B Owen
    Sripathi M Sureban
    Naushad Ali
    Ralf Janknecht
    Courtney W Houchen
    Molecular Cancer, 13
  • [3] LRRK2-In-1 Inhibit Proliferation of Doublecortin and CaM Kinase-Like-1 (DCLK1)-Positive Lung Cancer Cells
    Tao, Hiroyuki
    Mimura-Kimura, Yuka
    Mimura, Yusuke
    Hara, Akio
    Murakami, Daigo
    Furukawa, Masashi
    Hayashi, Masataro
    Okabe, Kazunori
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1101 - S1102
  • [4] Chemoproteomics Reveals the Antiproliferative Potential of Parkinson's Disease Kinase Inhibitor LRRK2-IN-1 by Targeting PCNA Protein
    Li, Weichao
    Zhou, Yiqing
    Tang, Guanghui
    Wong, Nai-Kei
    Yang, Mengquan
    Tan, Dan
    Xiao, Youli
    MOLECULAR PHARMACEUTICS, 2018, 15 (08) : 3252 - 3259
  • [5] Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects
    Nevi, L.
    Di Matteo, S.
    Carpino, G.
    Cardinale, V.
    Zizzari, I.
    Ambrosino, V.
    Costantini, D.
    Safarikia, S.
    Manzi, E.
    Derose, A. M.
    Melandro, F.
    Bragazzi, M. C.
    Grazi, G.
    Berloco, P. B.
    Giuliante, F.
    Gaudio, E.
    Alvaro, D.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 5 - 6
  • [6] DOUBLECORTIN-LIKE KINASE 1 (DCLK1) IS A MARKER OF SPECIFIC SUBPOPULATIONS OF CANCER STEM CELLS (CSCS) IN HUMAN CHOLANGIOCARCINOMA (CCA) AND ITS INHIBITION EXERTS ANTI-CANCER EFFECTS
    Nevi, L.
    Di Matteo, S.
    Carpino, G.
    Cardinale, V.
    Ambrosino, V.
    Costantini, D.
    Safarikia, S.
    Manzi, E.
    De Rosa, A. M.
    Melandro, F.
    Bragazzi, M. C.
    Grazi, G.
    Berloco, P. B.
    Giuliante, F.
    Gaudio, E.
    Alvaro, D.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E86 - E87
  • [7] PTC-209, A TRANSCRIPTIONAL SMALL MOLECULE INHIBITOR OF BMI-1, DEMONSTRATES POTENT ANTI-MYELOMA ACTIVITY IN VITRO
    Bolomsky, A.
    Ludwig, H.
    HAEMATOLOGICA, 2015, 100 : 77 - 78
  • [8] ARTS-021 is a potent and selective CDK2 inhibitor that demonstrates anti-cancer activity in preclinical cancer models with CCNE1 amplification
    Liang, Jiaqi
    Cheng, Dai
    Guo, Yali
    Zhang, Xiaobin
    Liu, Xipan
    Fu, Jia
    Ding, Qiang
    Xiong, Wen
    Li, Fang
    Chen, Yaoyu
    Sheng, Qing
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment
    Ouyang, Liang
    Zhang, Lan
    Zhang, Shouyue
    Yao, Dahong
    Zhao, Yuqian
    Wang, Guan
    Fu, Leilei
    Lei, Peng
    Liu, Bo
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (07) : 2776 - 2792
  • [10] S-222611, a potent, orally active small molecule inhibitor of EGFR and HER2: in vitro kinase inhibition and antitumor activity
    Hirata, Michinari
    Tanaka, Hidekazu
    Dohi, Keiji
    Iguchi, Motofumi
    Wada, Tohru
    Matsuo, Kenji
    Kume, Masaharu
    Omori, Naoki
    Tada, Yukio
    Orita, Satoshi
    Abe, Kenji
    Arimura, Akinori
    Matsuo, Yoshiyuki
    Kato, Akira
    CANCER RESEARCH, 2009, 69
12345